Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO30377 | Cinchona ledgeriana | Species | Rubiaceae | Eukaryota | TCM_Taiwan* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 110 | nM | 15026051 |
NPT1759 | Cell Line | FM3A | Mus musculus | EC50 | = | 100000 | nM | 15026051 |
NPT2 | Others | Unspecified | Kd | = | 556000 | nM | 10821711 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.1596 | ug/ml | 12213073 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.1499 | ug/ml | 12213073 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0996 | ug/ml | 12213073 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.00908 | ug/ml | 12213073 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | ED50 | = | 83 | mg/kg | 12213073 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | ED90 | = | 1050 | mg/kg | 12213073 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | ED50 | = | 71 | mg/kg | 12213073 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | ED90 | = | 118 | mg/kg | 12213073 |
NPT475 | Organism | Plasmodium yoelii | Plasmodium yoelii | ED50 | = | 120 | mg/kg | 12213073 |
NPT475 | Organism | Plasmodium yoelii | Plasmodium yoelii | ED90 | = | 56 | mg/kg | 12213073 |
NPT475 | Organism | Plasmodium yoelii | Plasmodium yoelii | ED50 | = | 128 | mg/kg | 12213073 |
NPT475 | Organism | Plasmodium yoelii | Plasmodium yoelii | ED90 | = | 29 | mg/kg | 12213073 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 380 | nM | 11212126 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 110 | nM | 11855978 |
NPT1759 | Cell Line | FM3A | Mus musculus | EC50 | = | 100000 | nM | 11855978 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.00361 | ug/ml | 2657065 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.059 | ug/ml | 2657065 |
NPT1774 | Protein Family | Sodium channel alpha subunits; brain (Types I, II, III) | Homo sapiens | IC50 | = | 4400 | nM | 2579237 |
NPT1774 | Protein Family | Sodium channel alpha subunits; brain (Types I, II, III) | Homo sapiens | Inhibition | = | 69.3 | % | 2579237 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 380 | nM | 11844668 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 96 | nM | 11844668 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 380 | nM | 12217353 |
NPT2 | Others | Unspecified | Ratio | = | 1 | 7009867 | ||
NPT2 | Others | Unspecified | IC50 | = | 0.17 | ug/ml | 12127529 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 100 | nM | 8182707 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 48 | nM | 8182707 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC99 | = | 300 | nM | 8182707 |
NPT2964 | Others | Ferriprotoporphyrin IX | Plasmodium falciparum | IC50 | = | 80 | ug/ml | 12873511 |
NPT2964 | Others | Ferriprotoporphyrin IX | Plasmodium falciparum | IC50 | = | 250000 | nM | 12873511 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 110 | nM | 10937718 |
NPT1759 | Cell Line | FM3A | Mus musculus | EC50 | = | 100000 | nM | 10937718 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 380 | nM | 12798326 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Ki | = | 12000 | nM | 12477351 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 430000 | nM | 12477351 |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | IC50 | = | 1800 | nM | 16610785 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 110 | nM | 16524728 |
NPT1759 | Cell Line | FM3A | Mus musculus | EC50 | = | 100000 | nM | 16524728 |
NPT1759 | Cell Line | FM3A | Mus musculus | Ratio EC50 | = | 910 | 16524728 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 66.52 | nM | 17116676 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 69.19 | nM | 17116676 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 62.77 | nM | 17116676 |
NPT3035 | Cell Line | ScN2a | Mus musculus | IC50 | = | 10000 | nM | 17850126 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 11 | nM | 18023189 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 60 | nM | 18023189 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0158 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.1675 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0113 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.1285 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0149 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.1623 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0119 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0923 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.005 | ug/ml | 17371812 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.036 | ug/ml | 17371812 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 70.35 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 78.03 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 60.7 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 115.16 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 146.94 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 160.38 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 165.01 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 94.35 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 99.32 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 103.56 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 110.94 | % | 18024584 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Kd | = | 309029.54 | nM | 18348514 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0194 | ug/ml | 1800638 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.1144 | ug/ml | 1800638 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 269 | nM | 11170658 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC90 | = | 1913 | nM | 11170658 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 413 | nM | 11170658 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC90 | = | 1718 | nM | 11170658 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | > | 20 | ug/ml | 11421741 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.041 | ug/ml | 11421741 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.009 | ug/ml | 11421741 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0196 | ug/ml | 11575956 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.102 | ug/ml | 11575956 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0176 | ug/ml | 9249972 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.102 | ug/ml | 9249972 |
NPT485 | Organism | Plasmodium falciparum (isolate K1 / Thailand) | Plasmodium falciparum K1 | IC50 | = | 0.0352 | ug/ml | 9249972 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0148 | ug/ml | 9134742 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0349 | ug/ml | 9134742 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Activity | = | 264 | % | 9134742 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Activity | = | 57.3 | % | 9134742 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | > | 20 | ug/ml | 9134742 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0157 | ug/ml | 8786363 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0388 | ug/ml | 8786363 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | > | 20 | ug/ml | 8759172 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0111 | ug/ml | 8759172 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 1800 | 8759172 | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0546 | ug/ml | 8759172 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 370 | 8759172 | ||
NPT612 | Individual Protein | Canalicular multispecific organic anion transporter 1 | Homo sapiens | Activity | = | 75 | % | 18457386 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | IC50 | = | 51600 | nM | 18788725 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | 60.2 | % | 18788725 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 220 | nM | 19282186 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 9.4 | ug/ml | 8229016 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 24.5 | ug/ml | 8229016 |
NPT2 | Others | Unspecified | Ratio ED50 | > | 2130 | 8229016 | ||
NPT2 | Others | Unspecified | Ratio ED50 | > | 820 | 8229016 | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 9.4 | ug/ml | 8254346 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 24.5 | ug/ml | 8254346 |
NPT2 | Others | Unspecified | Ratio ED50 | > | 2130 | 8254346 | ||
NPT2 | Others | Unspecified | Ratio ED50 | > | 820 | 8254346 | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 20.8 | ug/ml | 7528786 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 59.2 | ug/ml | 7528786 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0686 | ug/ml | 8289064 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.012 | ug/ml | 8289064 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | > | 5 | ug/ml | 8450318 |
NPT2 | Others | Unspecified | ED50 | > | 20 | ug/ml | 8450318 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 7.6 | ug/ml | 8450318 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 30.8 | ug/ml | 8450318 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 7.6 | ug/ml | 8450319 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | ED50 | = | 30.8 | ug/ml | 8450319 |
NPT2 | Others | Unspecified | Ratio ED50 | > | 2631 | 8450319 | ||
NPT2 | Others | Unspecified | Ratio ED50 | = | 649 | 8450319 | ||
NPT453 | Cell Line | HT-1080 | Homo sapiens | ED50 | > | 20 | ug/ml | 8450319 |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | ED50 | > | 20 | ug/ml | 8450319 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | > | 20 | ug/ml | 8450319 |
NPT2 | Others | Unspecified | Ratio ED50 | = | 2916 | 8450319 | ||
NPT2 | Others | Unspecified | Ratio ED50 | = | 737 | 8450319 | ||
NPT2 | Others | Unspecified | Ratio ED50 | = | 182 | 8450319 | ||
NPT168 | Cell Line | P388 | Mus musculus | ED50 | > | 5 | ug/ml | 8450319 |
NPT2 | Others | Unspecified | Ratio ED50 | > | 658 | 8450319 | ||
NPT762 | Cell Line | A-431 | Homo sapiens | ED50 | > | 20 | ug/ml | 8450319 |
NPT858 | Cell Line | LNCaP | Homo sapiens | ED50 | > | 20 | ug/ml | 8450319 |
NPT133 | Cell Line | ZR-75-1 | Homo sapiens | ED50 | = | 1.2 | ug/ml | 8450319 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | > | 20 | ug/ml | 1294700 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0102 | ug/ml | 1294700 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0238 | ug/ml | 1294700 |
NPT2249 | Individual Protein | Histidine-rich protein | Plasmodium falciparum | IC50 | = | 7400000000 | nM | 15921407 |
NPT2 | Others | Unspecified | IC50 | > | 3.60E+11 | nM | 15921407 | |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | > | 55400 | nM | 9917283 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 23.38 | nM | 9917283 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 250 | nM | 9917283 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 67 | ug/ml | 16441070 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 25 | ug/ml | 16441070 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | > | 20 | ug/ml | 16933872 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.011 | ug/ml | 16933872 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.029 | ug/ml | 16933872 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 1830 | 16933872 | ||
NPT2 | Others | Unspecified | Ratio IC50 | > | 700 | 16933872 | ||
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | = | 100 | ug/ml | 19188070 |
NPT485 | Organism | Plasmodium falciparum (isolate K1 / Thailand) | Plasmodium falciparum K1 | IC50 | = | 12 | nM | 19084293 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 26 | % | 20017491 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 7.3 | % | 20017491 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 11.6 | % | 20017491 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 14 | % | 20017491 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 32 | % | 20017491 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 45 | % | 20017491 |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 0 | % | 20017491 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.04 | ug/ml | 20149652 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC90 | = | 0.09 | ug/ml | 20149652 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 180 | nM | 19747753 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 54000 | nM | 20185316 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 66 | nM | 19258269 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 70 | nM | 19258269 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 77.13 | nM | 18443109 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 73.96 | nM | 18443109 |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 9410 | nM | 21199921 |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 9530 | nM | 21199921 |
NPT841 | Organism | Leishmania major | Leishmania major | Ratio EC50 | = | 1 | 21199921 | |
NPT1 | Others | Radical scavenging activity | Activity | = | 2.65 | % | 21377771 | |
NPT2 | Others | Unspecified | IC50 | = | 65800 | nM | 21377771 | |
NPT2 | Others | Unspecified | Activity | = | 1.22 | % | 21377771 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 140 | nM | 21377771 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.268 | ug/ml | 22652224 |
NPT705 | Individual Protein | Solute carrier family 22 member 5 | Homo sapiens | Activity | = | 7.1 | % | 10525100 |
NPT1543 | Individual Protein | Solute carrier family 22 member 4 | Homo sapiens | Activity | = | 24.6 | % | 10215651 |
NPT4360 | Individual Protein | Solute carrier family 22 member 1 | Mus musculus | IC50 | = | 280 | nM | 12176030 |
NPT435 | Individual Protein | Solute carrier family 22 member 1 | Rattus norvegicus | IC50 | = | 900 | nM | 12438515 |
NPT435 | Individual Protein | Solute carrier family 22 member 1 | Rattus norvegicus | IC50 | = | 1100 | nM | 12438515 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 112400 | nM | 11716514 |
NPT1544 | Individual Protein | Solute carrier family 22 member 2 | Rattus norvegicus | IC50 | = | 13000 | nM | 12438515 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 159300 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 167800 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 184900 | nM | 11716514 |
NPT4361 | Individual Protein | Solute carrier family 22 member 2 | Mus musculus | IC50 | = | 2800 | nM | 12176030 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 22600 | nM | 11716514 |
NPT1544 | Individual Protein | Solute carrier family 22 member 2 | Rattus norvegicus | IC50 | = | 38000 | nM | 12438515 |
NPT435 | Individual Protein | Solute carrier family 22 member 1 | Rattus norvegicus | IC50 | = | 4100 | nM | 11502595 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 74400 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 87600 | nM | 11716514 |
NPT435 | Individual Protein | Solute carrier family 22 member 1 | Rattus norvegicus | Ki | = | 930 | nM | 7990927 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Ki | = | 22900 | nM | 9655880 |
NPT1540 | Individual Protein | Solute carrier family 22 member 2 | Homo sapiens | Ki | = | 3400 | nM | 9260930 |
NPT305 | Individual Protein | Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus | Ki | = | 3810 | nM | 11883641 |
NPT435 | Individual Protein | Solute carrier family 22 member 1 | Rattus norvegicus | Ki | = | 4300 | nM | 8878062 |
NPT1544 | Individual Protein | Solute carrier family 22 member 2 | Rattus norvegicus | Ki | = | 55000 | nM | 11502595 |
NPT752 | Individual Protein | Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus | Ki | = | 76700 | nM | 11883641 |
NPT622 | Individual Protein | Solute carrier organic anion transporter family member 2B1 | Homo sapiens | Inhibition | = | -22.9 | % | 22541068 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | -1.3 | % | 22541068 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 54 | % | 22541068 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 29 | ug/ml | 10.1007/s00044-012-0328-z |
NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Inhibition | < | 50 | % | 23927658 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.268 | ug/ml | 24681985 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.268 | ug/ml | 25016227 |
NPT485 | Organism | Plasmodium falciparum (isolate K1 / Thailand) | Plasmodium falciparum K1 | IC50 | = | 113 | nM | 25747499 |
NPT757 | Organism | Plasmodium falciparum 3D7 | Plasmodium falciparum 3D7 | IC50 | = | 80 | nM | 25747499 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 199 | nM | 25747499 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 431 | nM | 25747499 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 826 | nM | 26900659 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC118832 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC329708 |
1.0 | High Similarity | NPC47059 |
1.0 | High Similarity | NPC264166 |
1.0 | High Similarity | NPC274291 |
1.0 | High Similarity | NPC165349 |
0.8808 | High Similarity | NPC472111 |
0.8674 | High Similarity | NPC203754 |
0.8674 | High Similarity | NPC150048 |
0.82 | Intermediate Similarity | NPC193238 |
0.8154 | Intermediate Similarity | NPC251090 |
0.8144 | Intermediate Similarity | NPC307963 |
0.8119 | Intermediate Similarity | NPC469589 |
0.8081 | Intermediate Similarity | NPC249040 |
0.805 | Intermediate Similarity | NPC475774 |
0.8041 | Intermediate Similarity | NPC92111 |
0.803 | Intermediate Similarity | NPC4071 |
0.803 | Intermediate Similarity | NPC476582 |
0.803 | Intermediate Similarity | NPC476578 |
0.8009 | Intermediate Similarity | NPC295228 |
0.8 | Intermediate Similarity | NPC202605 |
0.8 | Intermediate Similarity | NPC112206 |
0.799 | Intermediate Similarity | NPC76748 |
0.797 | Intermediate Similarity | NPC475841 |
0.797 | Intermediate Similarity | NPC474145 |
0.7938 | Intermediate Similarity | NPC296527 |
0.7921 | Intermediate Similarity | NPC476581 |
0.7921 | Intermediate Similarity | NPC36229 |
0.7921 | Intermediate Similarity | NPC16452 |
0.7906 | Intermediate Similarity | NPC219963 |
0.79 | Intermediate Similarity | NPC329793 |
0.7895 | Intermediate Similarity | NPC469594 |
0.7892 | Intermediate Similarity | NPC477111 |
0.7874 | Intermediate Similarity | NPC471080 |
0.7874 | Intermediate Similarity | NPC469592 |
0.783 | Intermediate Similarity | NPC280272 |
0.7826 | Intermediate Similarity | NPC26679 |
0.7819 | Intermediate Similarity | NPC252590 |
0.7817 | Intermediate Similarity | NPC133140 |
0.7817 | Intermediate Similarity | NPC195268 |
0.7816 | Intermediate Similarity | NPC5145 |
0.7811 | Intermediate Similarity | NPC315957 |
0.7811 | Intermediate Similarity | NPC176538 |
0.7805 | Intermediate Similarity | NPC82548 |
0.7799 | Intermediate Similarity | NPC470799 |
0.7799 | Intermediate Similarity | NPC8022 |
0.7799 | Intermediate Similarity | NPC477110 |
0.7789 | Intermediate Similarity | NPC473053 |
0.7788 | Intermediate Similarity | NPC469554 |
0.7788 | Intermediate Similarity | NPC266931 |
0.7784 | Intermediate Similarity | NPC177404 |
0.7778 | Intermediate Similarity | NPC289786 |
0.7778 | Intermediate Similarity | NPC226202 |
0.7772 | Intermediate Similarity | NPC31930 |
0.7766 | Intermediate Similarity | NPC473764 |
0.7766 | Intermediate Similarity | NPC314940 |
0.7762 | Intermediate Similarity | NPC476041 |
0.7762 | Intermediate Similarity | NPC304926 |
0.7761 | Intermediate Similarity | NPC287437 |
0.7756 | Intermediate Similarity | NPC313189 |
0.775 | Intermediate Similarity | NPC267928 |
0.775 | Intermediate Similarity | NPC224928 |
0.7744 | Intermediate Similarity | NPC171171 |
0.774 | Intermediate Similarity | NPC472098 |
0.772 | Intermediate Similarity | NPC161887 |
0.772 | Intermediate Similarity | NPC266551 |
0.7718 | Intermediate Similarity | NPC475910 |
0.7707 | Intermediate Similarity | NPC477113 |
0.7706 | Intermediate Similarity | NPC101543 |
0.7704 | Intermediate Similarity | NPC66083 |
0.7692 | Intermediate Similarity | NPC314002 |
0.7692 | Intermediate Similarity | NPC208284 |
0.7689 | Intermediate Similarity | NPC213530 |
0.7689 | Intermediate Similarity | NPC193267 |
0.7688 | Intermediate Similarity | NPC124542 |
0.7688 | Intermediate Similarity | NPC471177 |
0.7688 | Intermediate Similarity | NPC59779 |
0.7681 | Intermediate Similarity | NPC185782 |
0.7671 | Intermediate Similarity | NPC255800 |
0.7671 | Intermediate Similarity | NPC96584 |
0.7661 | Intermediate Similarity | NPC201508 |
0.7659 | Intermediate Similarity | NPC470500 |
0.7659 | Intermediate Similarity | NPC475070 |
0.7656 | Intermediate Similarity | NPC296482 |
0.7656 | Intermediate Similarity | NPC202768 |
0.7656 | Intermediate Similarity | NPC53069 |
0.7653 | Intermediate Similarity | NPC472099 |
0.765 | Intermediate Similarity | NPC26872 |
0.7647 | Intermediate Similarity | NPC118511 |
0.7644 | Intermediate Similarity | NPC312872 |
0.7644 | Intermediate Similarity | NPC290689 |
0.7642 | Intermediate Similarity | NPC173080 |
0.7641 | Intermediate Similarity | NPC204717 |
0.7638 | Intermediate Similarity | NPC99666 |
0.7635 | Intermediate Similarity | NPC234197 |
0.7623 | Intermediate Similarity | NPC81175 |
0.7622 | Intermediate Similarity | NPC26850 |
0.7621 | Intermediate Similarity | NPC323345 |
0.7621 | Intermediate Similarity | NPC470164 |
0.761 | Intermediate Similarity | NPC245816 |
0.761 | Intermediate Similarity | NPC476138 |
0.7606 | Intermediate Similarity | NPC471178 |
0.759 | Intermediate Similarity | NPC220765 |
0.7585 | Intermediate Similarity | NPC135549 |
0.7581 | Intermediate Similarity | NPC122463 |
0.7573 | Intermediate Similarity | NPC285558 |
0.7571 | Intermediate Similarity | NPC316981 |
0.757 | Intermediate Similarity | NPC174049 |
0.7569 | Intermediate Similarity | NPC314954 |
0.7565 | Intermediate Similarity | NPC326575 |
0.7565 | Intermediate Similarity | NPC283152 |
0.7551 | Intermediate Similarity | NPC62069 |
0.7549 | Intermediate Similarity | NPC477019 |
0.7549 | Intermediate Similarity | NPC19872 |
0.7548 | Intermediate Similarity | NPC287208 |
0.7545 | Intermediate Similarity | NPC475720 |
0.7545 | Intermediate Similarity | NPC474192 |
0.7539 | Intermediate Similarity | NPC121658 |
0.7539 | Intermediate Similarity | NPC14651 |
0.7538 | Intermediate Similarity | NPC3715 |
0.7536 | Intermediate Similarity | NPC478074 |
0.7535 | Intermediate Similarity | NPC310118 |
0.7524 | Intermediate Similarity | NPC223427 |
0.7523 | Intermediate Similarity | NPC110151 |
0.7513 | Intermediate Similarity | NPC472122 |
0.7513 | Intermediate Similarity | NPC24594 |
0.7513 | Intermediate Similarity | NPC42591 |
0.7512 | Intermediate Similarity | NPC279401 |
0.7512 | Intermediate Similarity | NPC79293 |
0.75 | Intermediate Similarity | NPC176127 |
0.7488 | Intermediate Similarity | NPC96405 |
0.7488 | Intermediate Similarity | NPC132642 |
0.7488 | Intermediate Similarity | NPC171409 |
0.7487 | Intermediate Similarity | NPC187827 |
0.7487 | Intermediate Similarity | NPC476518 |
0.7487 | Intermediate Similarity | NPC472105 |
0.7477 | Intermediate Similarity | NPC473822 |
0.7476 | Intermediate Similarity | NPC123976 |
0.7476 | Intermediate Similarity | NPC471304 |
0.7476 | Intermediate Similarity | NPC211813 |
0.7476 | Intermediate Similarity | NPC167860 |
0.7465 | Intermediate Similarity | NPC288349 |
0.7464 | Intermediate Similarity | NPC476465 |
0.7449 | Intermediate Similarity | NPC470474 |
0.7445 | Intermediate Similarity | NPC472434 |
0.7443 | Intermediate Similarity | NPC6215 |
0.7436 | Intermediate Similarity | NPC133261 |
0.7426 | Intermediate Similarity | NPC329541 |
0.7424 | Intermediate Similarity | NPC62510 |
0.7416 | Intermediate Similarity | NPC53344 |
0.7413 | Intermediate Similarity | NPC469390 |
0.7406 | Intermediate Similarity | NPC264176 |
0.7404 | Intermediate Similarity | NPC164374 |
0.7404 | Intermediate Similarity | NPC137929 |
0.7402 | Intermediate Similarity | NPC77555 |
0.74 | Intermediate Similarity | NPC32771 |
0.7397 | Intermediate Similarity | NPC103687 |
0.7397 | Intermediate Similarity | NPC132631 |
0.7395 | Intermediate Similarity | NPC204446 |
0.7394 | Intermediate Similarity | NPC84508 |
0.7393 | Intermediate Similarity | NPC11464 |
0.7393 | Intermediate Similarity | NPC470020 |
0.7391 | Intermediate Similarity | NPC470678 |
0.7389 | Intermediate Similarity | NPC99891 |
0.7385 | Intermediate Similarity | NPC184964 |
0.7371 | Intermediate Similarity | NPC149471 |
0.7371 | Intermediate Similarity | NPC162530 |
0.7371 | Intermediate Similarity | NPC271215 |
0.7349 | Intermediate Similarity | NPC473513 |
0.7346 | Intermediate Similarity | NPC174672 |
0.7346 | Intermediate Similarity | NPC476116 |
0.7346 | Intermediate Similarity | NPC174758 |
0.7345 | Intermediate Similarity | NPC475816 |
0.7343 | Intermediate Similarity | NPC232727 |
0.7339 | Intermediate Similarity | NPC216612 |
0.7337 | Intermediate Similarity | NPC20249 |
0.7333 | Intermediate Similarity | NPC288943 |
0.7333 | Intermediate Similarity | NPC134586 |
0.733 | Intermediate Similarity | NPC476167 |
0.7324 | Intermediate Similarity | NPC251160 |
0.7323 | Intermediate Similarity | NPC472110 |
0.7323 | Intermediate Similarity | NPC472109 |
0.732 | Intermediate Similarity | NPC111624 |
0.7318 | Intermediate Similarity | NPC214980 |
0.7317 | Intermediate Similarity | NPC156704 |
0.7311 | Intermediate Similarity | NPC188420 |
0.731 | Intermediate Similarity | NPC222592 |
0.731 | Intermediate Similarity | NPC168486 |
0.73 | Intermediate Similarity | NPC204385 |
0.7296 | Intermediate Similarity | NPC211997 |
0.7295 | Intermediate Similarity | NPC329747 |
0.7295 | Intermediate Similarity | NPC315491 |
0.7295 | Intermediate Similarity | NPC45459 |
0.729 | Intermediate Similarity | NPC476287 |
0.7289 | Intermediate Similarity | NPC477549 |
0.7286 | Intermediate Similarity | NPC284559 |
0.7284 | Intermediate Similarity | NPC137353 |
0.7282 | Intermediate Similarity | NPC192315 |
0.7282 | Intermediate Similarity | NPC239954 |
0.7277 | Intermediate Similarity | NPC473105 |
0.7273 | Intermediate Similarity | NPC469440 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC118832 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD31 | Approved |
1.0 | High Similarity | NPD4034 | Approved |
1.0 | High Similarity | NPD4037 | Approved |
1.0 | High Similarity | NPD4122 | Approved |
1.0 | High Similarity | NPD4039 | Approved |
1.0 | High Similarity | NPD4038 | Approved |
1.0 | High Similarity | NPD4035 | Approved |
1.0 | High Similarity | NPD32 | Approved |
1.0 | High Similarity | NPD4033 | Approved |
1.0 | High Similarity | NPD4036 | Approved |
0.8632 | High Similarity | NPD3478 | Clinical (unspecified phase) |
0.8632 | High Similarity | NPD3477 | Phase 2 |
0.8474 | Intermediate Similarity | NPD6569 | Phase 2 |
0.8201 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.82 | Intermediate Similarity | NPD7222 | Phase 2 |
0.8144 | Intermediate Similarity | NPD1038 | Approved |
0.8098 | Intermediate Similarity | NPD6872 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD4203 | Approved |
0.8 | Intermediate Similarity | NPD1856 | Discontinued |
0.8 | Intermediate Similarity | NPD4204 | Approved |
0.7959 | Intermediate Similarity | NPD1304 | Clinical (unspecified phase) |
0.7951 | Intermediate Similarity | NPD4502 | Phase 2 |
0.7931 | Intermediate Similarity | NPD7453 | Approved |
0.7931 | Intermediate Similarity | NPD7452 | Approved |
0.7927 | Intermediate Similarity | NPD4375 | Approved |
0.7921 | Intermediate Similarity | NPD4795 | Phase 2 |
0.7917 | Intermediate Similarity | NPD6494 | Phase 2 |
0.7885 | Intermediate Similarity | NPD5612 | Discontinued |
0.7869 | Intermediate Similarity | NPD5255 | Approved |
0.7868 | Intermediate Similarity | NPD6361 | Phase 2 |
0.7868 | Intermediate Similarity | NPD4551 | Phase 2 |
0.7848 | Intermediate Similarity | NPD6276 | Discontinued |
0.7847 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7828 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.7817 | Intermediate Similarity | NPD3922 | Approved |
0.7817 | Intermediate Similarity | NPD3921 | Approved |
0.7817 | Intermediate Similarity | NPD3924 | Approved |
0.7817 | Intermediate Similarity | NPD3923 | Approved |
0.7812 | Intermediate Similarity | NPD3386 | Phase 2 |
0.7811 | Intermediate Similarity | NPD4396 | Clinical (unspecified phase) |
0.7811 | Intermediate Similarity | NPD1739 | Approved |
0.7811 | Intermediate Similarity | NPD1740 | Approved |
0.7804 | Intermediate Similarity | NPD7675 | Phase 3 |
0.7804 | Intermediate Similarity | NPD7676 | Clinical (unspecified phase) |
0.7804 | Intermediate Similarity | NPD7674 | Phase 3 |
0.7773 | Intermediate Similarity | NPD3402 | Phase 1 |
0.7772 | Intermediate Similarity | NPD5522 | Clinical (unspecified phase) |
0.7761 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7749 | Intermediate Similarity | NPD1032 | Phase 2 |
0.7725 | Intermediate Similarity | NPD6568 | Discontinued |
0.7721 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7716 | Intermediate Similarity | NPD8063 | Discontinued |
0.7714 | Intermediate Similarity | NPD7112 | Discontinued |
0.7708 | Intermediate Similarity | NPD1620 | Clinical (unspecified phase) |
0.7707 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7704 | Intermediate Similarity | NPD1033 | Clinical (unspecified phase) |
0.7704 | Intermediate Similarity | NPD1034 | Phase 3 |
0.7704 | Intermediate Similarity | NPD6257 | Clinical (unspecified phase) |
0.77 | Intermediate Similarity | NPD6550 | Discontinued |
0.7692 | Intermediate Similarity | NPD4889 | Approved |
0.7689 | Intermediate Similarity | NPD6500 | Approved |
0.7689 | Intermediate Similarity | NPD6501 | Approved |
0.7688 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.7673 | Intermediate Similarity | NPD2177 | Approved |
0.7673 | Intermediate Similarity | NPD2175 | Phase 3 |
0.7673 | Intermediate Similarity | NPD5999 | Phase 2 |
0.7673 | Intermediate Similarity | NPD2176 | Approved |
0.7671 | Intermediate Similarity | NPD7558 | Phase 2 |
0.7667 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7656 | Intermediate Similarity | NPD6159 | Phase 2 |
0.7656 | Intermediate Similarity | NPD7069 | Discontinued |
0.7656 | Intermediate Similarity | NPD3815 | Phase 1 |
0.7656 | Intermediate Similarity | NPD3816 | Phase 1 |
0.765 | Intermediate Similarity | NPD6590 | Discontinued |
0.7634 | Intermediate Similarity | NPD9705 | Discontinued |
0.7634 | Intermediate Similarity | NPD112 | Approved |
0.7626 | Intermediate Similarity | NPD4081 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD2582 | Approved |
0.7622 | Intermediate Similarity | NPD2581 | Approved |
0.7608 | Intermediate Similarity | NPD5067 | Phase 2 |
0.7608 | Intermediate Similarity | NPD5066 | Phase 2 |
0.7604 | Intermediate Similarity | NPD6553 | Clinical (unspecified phase) |
0.7586 | Intermediate Similarity | NPD3825 | Phase 3 |
0.7585 | Intermediate Similarity | NPD1392 | Approved |
0.7576 | Intermediate Similarity | NPD4021 | Phase 2 |
0.7574 | Intermediate Similarity | NPD2952 | Discontinued |
0.7562 | Intermediate Similarity | NPD3395 | Approved |
0.7562 | Intermediate Similarity | NPD3396 | Approved |
0.7552 | Intermediate Similarity | NPD9690 | Approved |
0.7547 | Intermediate Similarity | NPD6147 | Clinical (unspecified phase) |
0.7545 | Intermediate Similarity | NPD7797 | Approved |
0.7545 | Intermediate Similarity | NPD7796 | Approved |
0.7538 | Intermediate Similarity | NPD6281 | Approved |
0.7536 | Intermediate Similarity | NPD5945 | Phase 1 |
0.7536 | Intermediate Similarity | NPD5944 | Phase 1 |
0.7525 | Intermediate Similarity | NPD2383 | Phase 1 |
0.7524 | Intermediate Similarity | NPD6991 | Approved |
0.7513 | Intermediate Similarity | NPD2381 | Approved |
0.7513 | Intermediate Similarity | NPD2380 | Approved |
0.7513 | Intermediate Similarity | NPD2382 | Approved |
0.7513 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7512 | Intermediate Similarity | NPD4437 | Phase 3 |
0.7512 | Intermediate Similarity | NPD9695 | Approved |
0.7489 | Intermediate Similarity | NPD5559 | Phase 2 |
0.7478 | Intermediate Similarity | NPD7859 | Phase 2 |
0.7477 | Intermediate Similarity | NPD3354 | Phase 2 |
0.7476 | Intermediate Similarity | NPD6477 | Clinical (unspecified phase) |
0.7476 | Intermediate Similarity | NPD5669 | Clinical (unspecified phase) |
0.7475 | Intermediate Similarity | NPD4919 | Phase 3 |
0.7475 | Intermediate Similarity | NPD4418 | Discontinued |
0.7475 | Intermediate Similarity | NPD4921 | Phase 3 |
0.7475 | Intermediate Similarity | NPD4920 | Clinical (unspecified phase) |
0.7467 | Intermediate Similarity | NPD8101 | Phase 3 |
0.7464 | Intermediate Similarity | NPD2187 | Approved |
0.7464 | Intermediate Similarity | NPD2189 | Approved |
0.7455 | Intermediate Similarity | NPD7729 | Clinical (unspecified phase) |
0.7454 | Intermediate Similarity | NPD5147 | Discontinued |
0.7453 | Intermediate Similarity | NPD1322 | Clinical (unspecified phase) |
0.7451 | Intermediate Similarity | NPD7889 | Clinical (unspecified phase) |
0.7448 | Intermediate Similarity | NPD1078 | Clinical (unspecified phase) |
0.7441 | Intermediate Similarity | NPD6220 | Phase 3 |
0.7438 | Intermediate Similarity | NPD5512 | Phase 3 |
0.7435 | Intermediate Similarity | NPD5862 | Discovery |
0.7433 | Intermediate Similarity | NPD4671 | Clinical (unspecified phase) |
0.7433 | Intermediate Similarity | NPD4669 | Clinical (unspecified phase) |
0.7433 | Intermediate Similarity | NPD4670 | Clinical (unspecified phase) |
0.743 | Intermediate Similarity | NPD4989 | Phase 2 |
0.7418 | Intermediate Similarity | NPD7538 | Clinical (unspecified phase) |
0.7416 | Intermediate Similarity | NPD5429 | Discontinued |
0.7407 | Intermediate Similarity | NPD6242 | Discontinued |
0.7405 | Intermediate Similarity | NPD6158 | Phase 2 |
0.7405 | Intermediate Similarity | NPD6476 | Clinical (unspecified phase) |
0.7402 | Intermediate Similarity | NPD6769 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD5640 | Discontinued |
0.7395 | Intermediate Similarity | NPD8109 | Clinical (unspecified phase) |
0.7395 | Intermediate Similarity | NPD4429 | Discontinued |
0.7391 | Intermediate Similarity | NPD6525 | Clinical (unspecified phase) |
0.7389 | Intermediate Similarity | NPD6491 | Clinical (unspecified phase) |
0.7387 | Intermediate Similarity | NPD3039 | Clinical (unspecified phase) |
0.7385 | Intermediate Similarity | NPD5751 | Clinical (unspecified phase) |
0.7381 | Intermediate Similarity | NPD5658 | Approved |
0.7381 | Intermediate Similarity | NPD2739 | Clinical (unspecified phase) |
0.7381 | Intermediate Similarity | NPD7671 | Approved |
0.7381 | Intermediate Similarity | NPD7672 | Approved |
0.7381 | Intermediate Similarity | NPD5528 | Clinical (unspecified phase) |
0.7381 | Intermediate Similarity | NPD5529 | Phase 1 |
0.7381 | Intermediate Similarity | NPD5863 | Clinical (unspecified phase) |
0.7376 | Intermediate Similarity | NPD4372 | Phase 1 |
0.7376 | Intermediate Similarity | NPD7567 | Approved |
0.7376 | Intermediate Similarity | NPD5022 | Discontinued |
0.7371 | Intermediate Similarity | NPD1923 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD3003 | Approved |
0.7358 | Intermediate Similarity | NPD5936 | Approved |
0.7358 | Intermediate Similarity | NPD5939 | Approved |
0.7358 | Intermediate Similarity | NPD3570 | Phase 2 |
0.7358 | Intermediate Similarity | NPD4131 | Phase 3 |
0.7347 | Intermediate Similarity | NPD3920 | Phase 2 |
0.7344 | Intermediate Similarity | NPD2781 | Approved |
0.7336 | Intermediate Similarity | NPD8100 | Phase 3 |
0.7333 | Intermediate Similarity | NPD6290 | Phase 2 |
0.7333 | Intermediate Similarity | NPD4344 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD4343 | Phase 1 |
0.733 | Intermediate Similarity | NPD2782 | Approved |
0.733 | Intermediate Similarity | NPD2780 | Approved |
0.733 | Intermediate Similarity | NPD925 | Approved |
0.733 | Intermediate Similarity | NPD926 | Approved |
0.733 | Intermediate Similarity | NPD7555 | Discontinued |
0.733 | Intermediate Similarity | NPD4548 | Discontinued |
0.7327 | Intermediate Similarity | NPD4148 | Approved |
0.7327 | Intermediate Similarity | NPD2334 | Discontinued |
0.7324 | Intermediate Similarity | NPD3330 | Phase 1 |
0.7317 | Intermediate Similarity | NPD7948 | Phase 1 |
0.7317 | Intermediate Similarity | NPD1622 | Discontinued |
0.7304 | Intermediate Similarity | NPD3810 | Clinical (unspecified phase) |
0.7302 | Intermediate Similarity | NPD6803 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD7589 | Clinical (unspecified phase) |
0.7295 | Intermediate Similarity | NPD484 | Approved |
0.7295 | Intermediate Similarity | NPD6219 | Discontinued |
0.7289 | Intermediate Similarity | NPD3006 | Discontinued |
0.7282 | Intermediate Similarity | NPD5065 | Approved |
0.7277 | Intermediate Similarity | NPD7169 | Suspended |
0.726 | Intermediate Similarity | NPD6824 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD4897 | Phase 2 |
0.7255 | Intermediate Similarity | NPD4526 | Approved |
0.7255 | Intermediate Similarity | NPD4529 | Approved |
0.7255 | Intermediate Similarity | NPD4528 | Approved |
0.725 | Intermediate Similarity | NPD7424 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7246 | Intermediate Similarity | NPD1768 | Approved |
0.7244 | Intermediate Similarity | NPD6963 | Approved |
0.7244 | Intermediate Similarity | NPD6964 | Approved |
0.7235 | Intermediate Similarity | NPD7395 | Discontinued |
0.7233 | Intermediate Similarity | NPD6988 | Phase 1 |
0.7231 | Intermediate Similarity | NPD2077 | Approved |
0.7231 | Intermediate Similarity | NPD2076 | Approved |
0.7225 | Intermediate Similarity | NPD6750 | Phase 2 |
0.7225 | Intermediate Similarity | NPD6975 | Discontinued |
0.7225 | Intermediate Similarity | NPD3931 | Approved |
0.7225 | Intermediate Similarity | NPD3928 | Approved |
Molecular Weight:   | 324.18 |
ALogP:   | -0.5136 |
MLogP:   | 3.22 |
XLogP:   | 2.662 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 45.59 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 24 |